Peptides of the innate immunity as potential anticancer agents: pros and cons
Surgical resection was the main approach to cancer therapy, often supplemented by radiation and chemotherapy. The effectiveness of such complex treatment in many cases remains low. In this regard, there is an urgent need to search for new compounds that have selective cytotoxic activity against tumo...
| 出版年: | Медицинская иммунология |
|---|---|
| 主要な著者: | A. N. Chernov, D. S. Orlov, O. V. Shamova |
| フォーマット: | 論文 |
| 言語: | ロシア語 |
| 出版事項: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2021-12-01
|
| 主題: | |
| オンライン・アクセス: | https://www.mimmun.ru/mimmun/article/view/2459 |
類似資料
Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells
著者:: Alexandr N. Chernov, 等
出版事項: (2022-08-01)
著者:: Alexandr N. Chernov, 等
出版事項: (2022-08-01)
Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
著者:: Qing Zhang, 等
出版事項: (2023-04-01)
著者:: Qing Zhang, 等
出版事項: (2023-04-01)
The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
著者:: Kengo eKuroda, 等
出版事項: (2015-06-01)
著者:: Kengo eKuroda, 等
出版事項: (2015-06-01)
Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
著者:: Fatai Lu, 等
出版事項: (2022-08-01)
著者:: Fatai Lu, 等
出版事項: (2022-08-01)
Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
著者:: Bapi Pahar, 等
出版事項: (2020-09-01)
著者:: Bapi Pahar, 等
出版事項: (2020-09-01)
Respiratory tract antimicrobial peptides more effectively killed multiple methicillin-resistant Staphylococcus aureus and nontypeable Haemophilus influenzae isolates after disruption from biofilm residence
著者:: Nikola Kurbatfinski, 等
出版事項: (2025-08-01)
著者:: Nikola Kurbatfinski, 等
出版事項: (2025-08-01)
Cathelicidin: Insights into Its Impact on Metabolic Syndrome and Chronic Inflammation
著者:: Alina Delia Popa, 等
出版事項: (2024-12-01)
著者:: Alina Delia Popa, 等
出版事項: (2024-12-01)
Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
著者:: Oriana Simonetti, 等
出版事項: (2021-10-01)
著者:: Oriana Simonetti, 等
出版事項: (2021-10-01)
Colonic epithelial cathelicidin (LL‐37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate
著者:: Ross J Porter, 等
出版事項: (2021-09-01)
著者:: Ross J Porter, 等
出版事項: (2021-09-01)
Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
著者:: Yihua Bei, 等
出版事項: (2019-02-01)
著者:: Yihua Bei, 等
出版事項: (2019-02-01)
Endopeptidase O promotes Streptococcus suis immune evasion by cleaving the host- defence peptide cathelicidins
著者:: Mingjie Jin, 等
出版事項: (2023-12-01)
著者:: Mingjie Jin, 等
出版事項: (2023-12-01)
Influence of Vitamin D Deficiency on the Level of Salivary cathelicidin LL-37 in relation to Dental Caries Experience: A Case-Control Study
著者:: Narjes M. Alhelfi, 等
出版事項: (2023-04-01)
著者:: Narjes M. Alhelfi, 等
出版事項: (2023-04-01)
Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
著者:: Karol Majewski, 等
出版事項: (2018-12-01)
著者:: Karol Majewski, 等
出版事項: (2018-12-01)
Prediction of recurrent currents of tooth decay among pregnant women laboratory method evaluation of antimicrobial activity of immunity oral liquid
著者:: V. A. Prohodnaja, 等
出版事項: (2015-04-01)
著者:: V. A. Prohodnaja, 等
出版事項: (2015-04-01)
Design of Protegrin-1 Analogs with Improved Antibacterial Selectivity
著者:: Ilia A. Bolosov, 等
出版事項: (2023-07-01)
著者:: Ilia A. Bolosov, 等
出版事項: (2023-07-01)
Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation
著者:: Alessandro Tossi, 等
出版事項: (2024-09-01)
著者:: Alessandro Tossi, 等
出版事項: (2024-09-01)
Transforming Cross-Linked Cyclic Dimers of KR-12 into Stable and Potent Antimicrobial Drug Leads
著者:: Taj Muhammad, 等
出版事項: (2023-02-01)
著者:: Taj Muhammad, 等
出版事項: (2023-02-01)
Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
著者:: Urszula Wnorowska, 等
出版事項: (2020-01-01)
著者:: Urszula Wnorowska, 等
出版事項: (2020-01-01)
Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients
著者:: Alexander N. Chernov, 等
出版事項: (2024-09-01)
著者:: Alexander N. Chernov, 等
出版事項: (2024-09-01)
Expression of the Antimicrobial Peptide SE-33-A2P, a Modified Analog of Cathelicidin, and an Analysis of Its Properties
著者:: Vagif Gasanov, 等
出版事項: (2024-02-01)
著者:: Vagif Gasanov, 等
出版事項: (2024-02-01)
Cathelicidin in Urinary Tract Diseases: Diagnostic, Prognostic and Therapeutic Potential of an Evolutionary Conserved Antimicrobial Protein
著者:: Iva Sorić Hosman, 等
出版事項: (2024-12-01)
著者:: Iva Sorić Hosman, 等
出版事項: (2024-12-01)
Novel Alligator Cathelicidin As-CATH8 Demonstrates Anti-Infective Activity against Clinically Relevant and Crocodylian Bacterial Pathogens
著者:: Felix L. Santana, 等
出版事項: (2022-11-01)
著者:: Felix L. Santana, 等
出版事項: (2022-11-01)
Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37
著者:: Yingxia Zhang, 等
出版事項: (2021-11-01)
著者:: Yingxia Zhang, 等
出版事項: (2021-11-01)
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
著者:: Kylen E. Ridyard, 等
出版事項: (2021-05-01)
著者:: Kylen E. Ridyard, 等
出版事項: (2021-05-01)
Epithelial-Immune Cell Crosstalk Determines the Activation of Immune Cells In Vitro by the Human Cathelicidin LL-37 at Low Physiological Concentrations
著者:: Ivan V. Bogdanov, 等
出版事項: (2023-08-01)
著者:: Ivan V. Bogdanov, 等
出版事項: (2023-08-01)
Rosacea as a General Medical Problem: Pathogenesis, Clinical Picture, Principles of Management
著者:: Sukhanov, Dmitriy S., 等
出版事項: (2024-10-01)
著者:: Sukhanov, Dmitriy S., 等
出版事項: (2024-10-01)
An M protein coiled coil unfurls and exposes its hydrophobic core to capture LL-37
著者:: Piotr Kolesinski, 等
出版事項: (2022-06-01)
著者:: Piotr Kolesinski, 等
出版事項: (2022-06-01)
Rosacea: prevalence, pathogenesis, particular features of clinical manifestations
著者:: A. A. Kubanova, 等
出版事項: (2017-08-01)
著者:: A. A. Kubanova, 等
出版事項: (2017-08-01)
Human Host Defense Peptide LL-37 Suppresses TNFα-Mediated Matrix Metalloproteinases MMP9 and MMP13 in Human Bronchial Epithelial Cells
著者:: Anthony Altieri, 等
出版事項: (2024-03-01)
著者:: Anthony Altieri, 等
出版事項: (2024-03-01)
Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in <i>Candida auris</i>
著者:: Irfan A. Rather, 等
出版事項: (2022-02-01)
著者:: Irfan A. Rather, 等
出版事項: (2022-02-01)
The role of endogenous antibacterial peptides in pneumonia occurrence among children of young age
著者:: G.O. Lezhenko, 等
出版事項: (2017-03-01)
著者:: G.O. Lezhenko, 等
出版事項: (2017-03-01)
Nasal cathelicidin is expressed in early life and is increased during mild, but not severe respiratory syncytial virus infection
著者:: Sofia Sintoris, 等
出版事項: (2024-06-01)
著者:: Sofia Sintoris, 等
出版事項: (2024-06-01)
Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant Klebsiella pneumoniae With mgrB Insertions
著者:: Hissa M. Al-Farsi, 等
出版事項: (2019-11-01)
著者:: Hissa M. Al-Farsi, 等
出版事項: (2019-11-01)
Vitamin-D and Innate Immunity in Children with Tuberculosis
著者:: Ehab abdelmoniem Albanna, 等
出版事項: (2014-08-01)
著者:: Ehab abdelmoniem Albanna, 等
出版事項: (2014-08-01)
The collectin SP-A and its trimeric recombinant fragment protect alveolar epithelial cells from the cytotoxic and proinflammatory effects of human cathelicidin in vitro
著者:: Lidia de Tapia, 等
出版事項: (2022-08-01)
著者:: Lidia de Tapia, 等
出版事項: (2022-08-01)
Role of Antimicrobial Peptides in Periodontal Health and Disease—A Review
著者:: Ruchita T Patil, 等
出版事項: (2025-05-01)
著者:: Ruchita T Patil, 等
出版事項: (2025-05-01)
Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37
著者:: Miyoko Tatsuta, 等
出版事項: (2019-11-01)
著者:: Miyoko Tatsuta, 等
出版事項: (2019-11-01)
Chitosan-coated liposomal systems for delivery of antibacterial peptide LL17-32 to Porphyromonas gingivalis
著者:: Jinyang Han, 等
出版事項: (2024-07-01)
著者:: Jinyang Han, 等
出版事項: (2024-07-01)
Antimicrobial Peptides as Mediators of Innate Immunity in Teleosts
著者:: Barbara A. Katzenback
出版事項: (2015-09-01)
著者:: Barbara A. Katzenback
出版事項: (2015-09-01)
Protegrin-1 and Analogues Against <i>Acinetobacter baumannii</i>: A Narrative Review
著者:: Giulio Rizzetto, 等
出版事項: (2025-02-01)
著者:: Giulio Rizzetto, 等
出版事項: (2025-02-01)
類似資料
-
Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells
著者:: Alexandr N. Chernov, 等
出版事項: (2022-08-01) -
Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
著者:: Qing Zhang, 等
出版事項: (2023-04-01) -
The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
著者:: Kengo eKuroda, 等
出版事項: (2015-06-01) -
Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
著者:: Fatai Lu, 等
出版事項: (2022-08-01) -
Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
著者:: Bapi Pahar, 等
出版事項: (2020-09-01)
